Sorof J M, Hawkins E P, Brewer E D, Boydstun I I, Kale A S, Powell D R
Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston 77030-2399, USA.
Pediatr Nephrol. 1998 Nov;12(9):764-8. doi: 10.1007/s004670050542.
In patients with proteinuria, African-American (AA) ethnicity is reported to be a risk factor for focal segmental glomerulosclereosis (FSGS) and its progression to end-stage renal disease (ESRD). We reviewed our single-center experience to determine the probability of FSGS and its progression to ESRD based on ethnicity and age at presentation in children with proteinuria with or without nephrotic syndrome. Proteinuria without systemic disease or acute glomerulonephritis was the presenting feature in 17% (236/1,403) of children in the renal patient database of Texas Children's Hospital, Baylor College of Medicine. Histopathological diagnoses were established in 107 of 236 patients (45%). FSGS was identified in 65 patients, accounting for 28% of all patients with proteinuria and 61% of patients who underwent renal biopsy. FSGS was more prevalent in AA (45%) than in non-AA patients (22%) (P=0.001), and AA patients with FSGS were older at presentation (12.7+/-4.4 years) than non-AA patients (5.6+/-4.6 years) (P<0.001). Among patients who underwent renal biopsy, increasing age at presentation increased the probability of having FSGS in AA but not non-AA patients (P=0.04). Five-year actuarial renal survival of FSGS was worse in AA (8%) than in non-AA patients (31%) (P=0.01). These data suggest an increased risk and worse outcome of FSGS in AA compared with non-AA children.
据报道,在蛋白尿患者中,非裔美国人(AA)族裔是局灶节段性肾小球硬化(FSGS)及其进展至终末期肾病(ESRD)的一个危险因素。我们回顾了我们单中心的经验,以确定基于蛋白尿患儿(无论有无肾病综合征)的族裔和就诊时年龄,FSGS及其进展至ESRD的可能性。在德克萨斯儿童医院、贝勒医学院的肾脏患者数据库中,17%(236/1403)的患儿以无全身性疾病或急性肾小球肾炎的蛋白尿为首发特征。236例患者中有107例(45%)确立了组织病理学诊断。65例患者被诊断为FSGS,占所有蛋白尿患者的28%,占接受肾活检患者的61%。FSGS在AA患者中(45%)比非AA患者中(22%)更常见(P=0.001),且患有FSGS的AA患者就诊时年龄(12.7±4.4岁)比非AA患者(5.6±4.6岁)大(P<0.001)。在接受肾活检的患者中,就诊时年龄增加会增加AA患者而非非AA患者患FSGS的可能性(P=0.04)。FSGS患者的5年精算肾脏生存率在AA患者中(8%)比非AA患者中(31%)更差(P=0.01)。这些数据表明,与非AA儿童相比,AA儿童患FSGS的风险增加且预后更差。